この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/8/221 分で読めます
Ranbaxy Laboratories Limited; Withdrawal of Approval of 27 Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of 27 abbreviated new drug applications (ANDAs) held by Ranbaxy Laboratories Ltd., c/o Ranbaxy Inc. (Ranbaxy), 600 College Rd. East, Princeton, NJ 08540. The drug products are no longer marketed, and Ranbaxy has requested that the approval of the applications be withdrawn.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →